logo
DivorceGo Expands Family Law Services Across Ontario

DivorceGo Expands Family Law Services Across Ontario

Globe and Mail02-06-2025
DivorceGo, a division of Bluetown Law, has expanded its reach across Ontario, aiming to make family law services more affordable and accessible for individuals navigating separation and divorce. With established offices in Toronto and Mississauga and legal services now offered in over a dozen additional cities, the firm is meeting growing demand for streamlined divorce solutions throughout the province.
DivorceGo operates under the leadership of Bluetown Law and provides a range of family law services, including uncontested and contested divorce, legal separation agreements, prenuptial contracts, notary services and foreign divorce opinion letters. Its main Toronto office is located at 45 Sheppard Ave. E., Suite 500, and its Mississauga location is at 2 Robert Speck Parkway, Suite 750.
'We see a clear need for professional legal support that's both affordable and accessible,' said Assad Bajwa, lead lawyer and accredited family mediator at Bluetown Law. 'Clients are often unsure where to start, and we aim to guide them through the legal process with clarity and compassion.'
In addition to the Greater Toronto Area, DivorceGo now serves clients in Richmond Hill, Brampton, Vaughan, Markham, Scarborough, North York, Ottawa, London, Windsor, Sudbury, Kingston, Barrie, Hamilton, Oakville, Kitchener, Guelph, Newmarket and Whitby.
The firm has built its reputation on offering cost-effective legal services, including flat-rate pricing for simple and uncontested divorces. These pricing models are designed to ease financial stress and promote access to justice. DivorceGo also offers free initial consultations, allowing potential clients to explore their legal options without upfront costs.
Accredited by both the Law Society of Ontario and the Better Business Bureau, DivorceGo has earned a reputation for professionalism and transparency. Clients frequently cite positive experiences with the firm's responsiveness, clear legal advice and straightforward approach.
To further enhance accessibility, the firm offers virtual consultations and online intake forms. This flexibility allows clients to receive support regardless of their location, particularly beneficial in rural or underserved areas.
'Whether a client is going through an uncontested divorce or requires legal help drafting a separation agreement, our role is to help them move forward with confidence,' Bajwa said. 'We're not just here to complete paperwork—we're here to help clients protect their rights and make informed decisions.'
The expansion aligns with broader trends in family law, where increasing numbers of couples are choosing out-of-court solutions to resolve legal issues. DivorceGo's approach focuses on minimizing conflict, reducing delays, and offering legal services that reflect the realities of modern family life.
With a growing presence across Ontario, DivorceGo remains focused on its mission: to simplify the divorce process, reduce legal costs, and support families with reliable legal guidance.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

DAZN and Fubo team up for (almost) all the soccer Canadians want
DAZN and Fubo team up for (almost) all the soccer Canadians want

Vancouver Sun

timea few seconds ago

  • Vancouver Sun

DAZN and Fubo team up for (almost) all the soccer Canadians want

A decade after streaming apps first shook up the Canadian TV sports rights scene, vibrations of a new shift are being felt. On Monday, DAZN and Fubo, who hold the bulk of the major European soccer leagues in their broadcast stables, confirmed what astute soccer viewers may have figured out a week ago: they're working together. In a Canada-only partnership, the two streamers will now have a subscription carved out on the other's service, allowing Canadians to start bundling their soccer fandom in one place. If they have not already set up year-long subscriptions in one place, that is. Start your day with a roundup of B.C.-focused news and opinion. By signing up you consent to receive the above newsletter from Postmedia Network Inc. A welcome email is on its way. If you don't see it, please check your junk folder. The next issue of Sunrise will soon be in your inbox. Please try again Interested in more newsletters? Browse here. In other words, if you've been subscribing to English Premier League on Fubo but have been eschewing DAZN's coverage of the UEFA Champions League, perhaps because you just didn't want to have several app subscriptions, you can now add a DAZN soccer package under the Fubo umbrella. That is going live any time. And the opposite is true — and indeed has been true for at least a week — if you are a DAZN subscriber, you can get EPL matches there again, by adding the Fubo sports option. DAZN previously held the rights to EPL but lost them to Fubo beginning in 2022. Fubo subscribers will now be able to add DAZN's 'premium' services inside the Fubo app, like the NFL, rugby and boxing on top of DAZN's soccer rights. (DAZN's pay per view events, like big-tent boxing nights, are not part of the Fubo deal.) This deal with Fubo has prompted DAZN to reset how you can subscribe to their service; previously their premium service gave you across the board access to their various feeds, including NFL Game Pass, UEFA club competitions like the Champions League, and more. DAZN now has three different packages: a basic subscription which gets you NFL, Champions League, Budesliga and more, basically what you've always had; second a 'DAZN+' package, which adds on the Fubo rights, including EPL and Serie A; third a package called DAZN Soccer, which only includes the soccer rights. Long-standing users of Fubo know that their service is more than just a soccer streamer: they've got MLB as well, plus CBC channels, One Soccer, beIN Sports and more. Adding more soccer, adding the NFL, is an exciting thing said Ben Grad, Fubo's Senior Vice-President, Strategic Partnerships and Operations. 'We were already the home of soccer in Canada, and it makes that even stronger,' Grad said. And so does striking a deal with DAZN to have EPL and Serie A land there too. It's a chance to put their brand in front of even more customers. Same goes for DAZN on Fubo. It's all win-win said Grad. 'It's not something that we've decided to distribute broadly,' it's super premium content,' he said. 'And I think they're (DAZN) really excited to enable their customers, or anyone who wants to their platform to have access to that. 'They're looking at us — I don't want to put words in their mouth — but I would imagine that, you know they've looked at us and how much we've been able to grow our own offering in Canada in just a few short years, and seeing like, hey, these guys have been really good at customer acquisition. They have a great content experience. They have some great content on there. It'd be great if we could plug into that and enable that to help grow.' Add it all up: if you want European soccer, you only need to look to one place, be it DAZN or Fubo … unless you want La Liga (TSN) or the FA Cup (Sportsnet). It's almost like we're going back to a universe we used to call 'cable.' pjohnston@

Canada builds homes faster in July, but gaps remain
Canada builds homes faster in July, but gaps remain

CTV News

timea few seconds ago

  • CTV News

Canada builds homes faster in July, but gaps remain

A construction worker works from a lift in a new housing development in Ottawa on Friday, Oct. 14, 2022. THE CANADIAN PRESS/Sean Kilpatrick Canada's home building is picking up, but not fast enough, according to new national numbers. In its July housing starts report published Monday, the Canada Mortgage and Housing Corporation says home building was four per cent faster than in June. If July's level held for 12 months, that would equal about 294,085 homes a year. But it still falls short of the agency's benchmark of 430,000 to 480,000 homes a year needed to restore pre-pandemic affordability. 'We're talking about doubling housing starts,' said Tania Bourassa-Ochoa, deputy chief economist at the CMHC. She added there are regional differences in the data. Most of the momentum came from multi-unit projects in the Prairie provinces and Quebec. Montreal posted a 212 per cent year-over-year increase in housing starts. Vancouver recorded a 24 per cent increase in July. However, in Toronto, housing starts fell 69 per cent year over year, with declines in both multi-unit and single-detached projects. For its size, P.E.I. built at roughly double the national rate in July, about 121 starts per 100,000 people, compared with about 56 across Canada. The Island's pattern also mirrors the national one, with multi-unit projects accounting for much of the increase. 'In some multi-units, we are quite a bit smaller,' said Sam Sanderson, executive director of the Construction Association of P.E.I. 'The ability to get permits, is maybe a little bit faster than other jurisdictions.' But the Island, like other provinces, still can't keep up with demand or the CMHC's affordability benchmark. In P.E.I., it would require lifting annual starts well beyond recent averages and building at or above historic highs. 'The shortage of skilled people will continue to be a problem in the years to come,' Sanderson said, citing challenges in reaching the benchmark. CMHC explains that one reason for July's increase is pre-planned projects reaching the 'start' stage now. The corporation records a housing start when the foundation is complete, which can be a year or two after a project is initiated. 'Even if we're seeing that increase and pick up in activity, that doesn't necessarily reflect developer sentiment,' Bourassa-Ochoa said. CMHC also projects activity could slow later this year, with higher costs and tariffs taking a toll. 'We've been in a context where the economy has been quite uncertain. We've had we've been facing geopolitical uncertainty as well,' said Bourassa-Ochoa. CMHC says the six-month average also rose 3.7 per cent in July. Both the monthly total of 23,464 urban starts and the year-to-date tally of 137,875 were 4 per cent above last year.

Cybin Announces Results of Annual Meeting of Shareholders
Cybin Announces Results of Annual Meeting of Shareholders

National Post

timea few seconds ago

  • National Post

Cybin Announces Results of Annual Meeting of Shareholders

Article content TORONTO — Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) (' Cybin ' or the ' Company '), a clinical-stage breakthrough neuropsychiatry company committed to advancing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce the voting results for each of the matters presented at the Company's annual meeting of shareholders held on August 18, 2025 (the ' Meeting '). There were 90 shareholders represented in person or by proxy at the Meeting holding 11,264,212 common shares, representing 48.92% of Cybin's total issued and outstanding common shares as at the record date for the Meeting. The voting results for each matter presented at the Meeting are set out below: Article content 1. Appointment of Auditor Article content Article content Zeifmans LLP was appointed auditor of Cybin until the next annual meeting of shareholders at renumeration to be fixed by the directors of Cybin. Voting results are set out below: Article content 2. Number of Directors Article content The special resolution to set the number of directors of Cybin at six was approved by at least two-thirds of the votes casts by the shareholders who voted in respect of the resolution present or represented by proxy at the Meeting. Voting results are set out below: Article content 3. Election of Directors Article content Each of the nominees for election as director listed in Cybin's management information circular dated July 14, 2025 were elected as directors of Cybin for the ensuing year or until their successors are elected or appointed. Voting results are set out below: Article content George Tziras did not stand for re-election as a director. The Company thanks Mr. Tziras for his past service. Article content About Cybin Article content Cybin is a late-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options to address the large unmet need for people who suffer from mental health conditions. Article content With promising proof-of-concept data, Cybin is working to change the mental health treatment landscape through the introduction of intermittent treatments that provide long lasting results. The Company is currently developing CYB003, a proprietary deuterated psilocin analog, in Phase 3 studies for the adjunctive treatment of major depressive disorder and CYB004, a proprietary deuterated N, N-dimethyltryptamine molecule in a Phase 2 study for generalized anxiety disorder. The Company also has a research pipeline of investigational, 5-HT-receptor focused compounds. Article content Founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland. For Company updates and to learn more about Cybin, visit or follow the team on X, LinkedIn, YouTube and Instagram. Article content Cautionary Notes and Forward-Looking Statements Article content Certain statements in this news release relating to the Company are forward-looking statements and are prospective in nature. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. These statements generally can be identified by the use of forward-looking words such as 'may', 'should', 'could', 'intend', 'estimate', 'plan', 'anticipate', 'expect', 'believe' or 'continue', or the negative thereof or similar variations. Forward-looking statements in this news release include statements regarding the Company's plans to engineer proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health conditions. Article content Any forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements of the Company to materially differ from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the psychedelics market; the ability of the Company to successfully achieve its business objectives; plans for growth; political, social and environmental uncertainties; employee relations; the presence of laws and regulations that may impose restrictions in the markets where the Company operates; implications of disease outbreaks on the Company's operations; and the risk factors set out in each of the Company's management's discussion and analysis for the year ended March 31, 2025 and the Company's annual information form for the year ended March 31, 2025, which are available under the Company's profile on SEDAR+ at and with the U.S. Securities and Exchange Commission on EDGAR at Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law. Article content Cybin makes no medical, treatment or health benefit claims about Cybin's proposed products. The U.S. Food and Drug Administration, Health Canada or other similar regulatory authorities have not evaluated claims regarding psilocin, psychedelic tryptamine, tryptamine derivatives or other psychedelic compounds. The efficacy of such products has not been confirmed by approved research. There is no assurance that the use of psilocin, psychedelic tryptamine, tryptamine derivatives or other psychedelic compounds can diagnose, treat, cure or prevent any disease or condition. Rigorous scientific research and clinical trials are needed. If Cybin cannot obtain the approvals or research necessary to commercialize its business, it may have a material adverse effect on Cybin's performance and operations. Article content Article content Article content Article content Contacts Article content Investor & Media Contact: Article content Article content Gabriel Fahel Article content Article content Chief Legal Officer Article content Article content Cybin Inc. Article content Article content Article content Article content

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store